Peter Reimnitz

1.2k total citations
32 papers, 912 citations indexed

About

Peter Reimnitz is a scholar working on Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health and Emergency Medical Services. According to data from OpenAlex, Peter Reimnitz has authored 32 papers receiving a total of 912 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 7 papers in Public Health, Environmental and Occupational Health and 7 papers in Emergency Medical Services. Recurrent topics in Peter Reimnitz's work include Pediatric health and respiratory diseases (7 papers), Streptococcal Infections and Treatments (7 papers) and Bacterial Identification and Susceptibility Testing (6 papers). Peter Reimnitz is often cited by papers focused on Pediatric health and respiratory diseases (7 papers), Streptococcal Infections and Treatments (7 papers) and Bacterial Identification and Susceptibility Testing (6 papers). Peter Reimnitz collaborates with scholars based in Germany, United States and Belgium. Peter Reimnitz's co-authors include B Hampel, Pierre Arvis, Jeff Alder, Tobias Welte, Inge C. Gyssens, Hugh Greville, Eva Polverino, Anthony De Soyza, Anne O’Donnell and Robert Wilson and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and European Respiratory Journal.

In The Last Decade

Peter Reimnitz

32 papers receiving 876 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Reimnitz Germany 17 329 251 126 126 121 32 912
Ainsley M. Sutherland Canada 14 226 0.7× 85 0.3× 111 0.9× 46 0.4× 83 0.7× 17 746
Nilgün Kültürsay Türkiye 20 307 0.9× 520 2.1× 28 0.2× 99 0.8× 179 1.5× 132 1.4k
Edoardo Picetti Italy 19 204 0.6× 213 0.8× 78 0.6× 177 1.4× 23 0.2× 55 1.0k
Lajos Kovács Canada 22 164 0.5× 507 2.0× 70 0.6× 80 0.6× 109 0.9× 55 1.1k
Mete Akısü Türkiye 19 252 0.8× 424 1.7× 26 0.2× 83 0.7× 153 1.3× 83 1.1k
Ajay J. Talati United States 19 224 0.7× 318 1.3× 44 0.3× 121 1.0× 112 0.9× 60 853
Kevin R. Kasten United States 22 405 1.2× 258 1.0× 91 0.7× 63 0.5× 88 0.7× 53 1.6k
Andrea Moscatelli Italy 15 151 0.5× 201 0.8× 40 0.3× 103 0.8× 34 0.3× 83 703
Hugh Paterson United Kingdom 18 185 0.6× 224 0.9× 41 0.3× 60 0.5× 55 0.5× 51 1.3k
Ioannis Pneumatikos Greece 22 465 1.4× 441 1.8× 41 0.3× 86 0.7× 53 0.4× 42 1.5k

Countries citing papers authored by Peter Reimnitz

Since Specialization
Citations

This map shows the geographic impact of Peter Reimnitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Reimnitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Reimnitz more than expected).

Fields of papers citing papers by Peter Reimnitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Reimnitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Reimnitz. The network helps show where Peter Reimnitz may publish in the future.

Co-authorship network of co-authors of Peter Reimnitz

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Reimnitz. A scholar is included among the top collaborators of Peter Reimnitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Reimnitz. Peter Reimnitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stappers, Mark H. T., Ferry Hagen, Peter Reimnitz, et al.. (2015). Bacteroides fragilis in biopsies of patients with major abscesses and diabetic foot infections: direct molecular versus culture-based detection. Diagnostic Microbiology and Infectious Disease. 85(2). 263–265. 4 indexed citations
2.
Stappers, Mark H. T., Ferry Hagen, Peter Reimnitz, et al.. (2015). Direct molecular versus culture-based assessment of Gram-positive cocci in biopsies of patients with major abscesses and diabetic foot infections. European Journal of Clinical Microbiology & Infectious Diseases. 34(9). 1885–1892. 15 indexed citations
3.
Stappers, Mark H. T., Marije Oosting, Mihai Ioana, et al.. (2015). Genetic Variation inTLR10, an Inhibitory Toll-Like Receptor, Influences Susceptibility to Complicated Skin and Skin Structure Infections. The Journal of Infectious Diseases. 212(9). 1491–1499. 22 indexed citations
4.
Stappers, Mark H. T., Marije Oosting, Theo S. Plantinga, et al.. (2014). TLR1, TLR2, and TLR6 Gene Polymorphisms Are Associated With Increased Susceptibility to Complicated Skin and Skin Structure Infections. The Journal of Infectious Diseases. 210(2). 311–318. 44 indexed citations
5.
Waele, Jan J. De, José M. Tellado, Jeff Alder, et al.. (2012). Randomised clinical trial of moxifloxacin versus ertapenem in complicated intra-abdominal infections: results of the PROMISE study. International Journal of Antimicrobial Agents. 41(1). 57–64. 17 indexed citations
6.
Wilson, Robert, Tobias Welte, Eva Polverino, et al.. (2012). Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study. European Respiratory Journal. 41(5). 1107–1115. 160 indexed citations
7.
Ulm, Lena, Hendrik Harms, Stephanie Ohlraun, Peter Reimnitz, & Andreas Meisel. (2012). Impact of infections on long-term outcome after severe middle cerebral artery infarction. Journal of the Neurological Sciences. 319(1-2). 15–17. 11 indexed citations
8.
9.
Harms, Hendrik, Peter Reimnitz, Georg Böhner, et al.. (2011). Influence of Stroke Localization on Autonomic Activation, Immunodepression, and Post-Stroke Infection. Cerebrovascular Diseases. 32(6). 552–560. 68 indexed citations
10.
Wilson, Robert C., Tobias Welte, Eva Polverino, et al.. (2011). Efficacy and safety of ciprofloxacin dry powder for inhalation in patients with non-cystic fibrosis bronchiectasis. European Respiratory Journal. 38(Suppl 55). 1929–1929. 5 indexed citations
11.
Hampel, B, et al.. (2011). Health status impact of ciprofloxacin dry powder for inhalation in patients with non-cystic fibrosis bronchiectasis. European Respiratory Journal. 38(Suppl 55). p2534–p2534. 1 indexed citations
12.
Alder, Jeff, Robert C. Wilson, Tobias Welte, et al.. (2011). Antimicrobial efficacy of ciprofloxacin dry powder for inhalation in patients with non-cystic fibrosis bronchiectasis. European Respiratory Journal. 38(Suppl 55). 1930–1930. 4 indexed citations
13.
Judlin, P., et al.. (2010). Efficacy and safety of moxifloxacin in uncomplicated pelvic inflammatory disease: the MONALISA study. BJOG An International Journal of Obstetrics & Gynaecology. 117(12). 1475–1484. 39 indexed citations
14.
Reimnitz, Peter, et al.. (2009). Moxifloxacin for the Treatment of Patients with Complicated Intra-abdominal Infections (the AIDA Study). Journal of Chemotherapy. 21(2). 170–180. 36 indexed citations
15.
Ott, Sebastian R., et al.. (2008). Moxifloxacin vs Ampicillin/Sulbactam in Aspiration Pneumonia and Primary Lung Abscess. Infection. 36(1). 23–30. 60 indexed citations
16.
Diener, Hans‐Christoph, Christian Lampl, Peter Reimnitz, & Michael Voelker. (2006). Aspirin in the treatment of acute migraine attacks. Expert Review of Neurotherapeutics. 6(4). 563–573. 28 indexed citations
17.
Ross, Jonathan, Tomasz Paszkowski, I. Rákóczi, et al.. (2006). Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial. Sexually Transmitted Infections. 82(6). 446–451. 47 indexed citations
18.
Siegert, R., Olof Berg, P Géhanno, et al.. (2003). Comparison of the efficacy and safety of faropenem daloxate and cefuroxime axetil for the treatment of acute bacterial maxillary sinusitis in adults. European Archives of Oto-Rhino-Laryngology. 260(4). 186–194. 20 indexed citations
19.
Reimnitz, Peter, et al.. (2000). Narkosezwischenfälle. Der Anaesthesist. 49(3). 187–195. 37 indexed citations
20.
Rohr, G., Peter Reimnitz, & Philipp Blanke. (1994). Treatment of hypertensive emergency. Intensive Care Medicine. 20(4). 268–271. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ainsley M. Sutherland Breakdown of academic impact, for papers by Nilgün Kültürsay Breakdown of academic impact, for papers by Edoardo Picetti Breakdown of academic impact, for papers by Lajos Kovács Breakdown of academic impact, for papers by Mete Akısü Breakdown of academic impact, for papers by Ajay J. Talati Breakdown of academic impact, for papers by Kevin R. Kasten Breakdown of academic impact, for papers by Andrea Moscatelli Breakdown of academic impact, for papers by Hugh Paterson Breakdown of academic impact, for papers by Ioannis Pneumatikos
Rankless by CCL
2026